Last reviewed · How we verify
Placebo foam — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo foam (Placebo foam) — Beijing Dayspring Pharmaceutical Technology Co., Ltd. Placebo foam is an inert formulation with no active pharmaceutical ingredient, serving as a control or vehicle for topical application.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo foam TARGET | Placebo foam | Beijing Dayspring Pharmaceutical Technology Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo foam CI watch — RSS
- Placebo foam CI watch — Atom
- Placebo foam CI watch — JSON
- Placebo foam alone — RSS
Cite this brief
Drug Landscape (2026). Placebo foam — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-foam. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab